tera.ai

Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

All entities

Entity

ACR-7280

product1 mentionslast seen Nov 6, 2026

First-in-class, oral, highly selective CDK11 inhibitor development candidate in IND-enabling studies.

Relationships 1

ACR-7280

Relationship

Acrivon Therapeutics, Inc.developsACR-7280

96% confidence1 supporting mentions

Either name opens that entity’s relationships.

Sources 1